Safety of teplizumab in patients with high-risk for diabetes mellitus type 1: A systematic review
{{output}}
Background: The incidence of diabetes mellitus type 1 (DM1) has been rising worldwide because of improvements in diagnostic techniques and improved access to care in countries with lower socioeconomic status. A new anti-CD4 antib... ...
